Table 2.

PPARγ protein expression in human monocytes and macrophages

Treatment	Monocytes (n = 5)	MDM (n = 5)
Control	0.4 ± 0.03	1.5 ± 0.1°°
+15d-PGJ2 (10 µM)	0.9 ± 0.05*	3 ± 0.2*
+Rosi (1 µM)	1.1 ± 0.1*	3.5 ± 0.2*
+MPs (10 µg·mL−1)	0.8 ± 0.1*	2.9 ± 0.2*
+MPs (1 µg·mL−1)	0.45 ± 0.1	1.7 ± 0.1

PPARγ protein expression was semi-quantified by measuring the ratio between PPARγ expression and β-actin expression. Rosi: rosiglitazone. Data are expressed as mean ± SEM of five experiments.

^*P < 0.05 versus Control (unstimulated cells of the same type)

^°°P < 0.01 versus control monocytes.